Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102.
Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $102
Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Hold to Outperform and raises the price target from $89 to $102.
Related Posts
Dime Community Bancshares Q2 EPS $1.01 Beats $0.84 Estimate
Dime Community Bancshares (NASDAQ:DCOM) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.84 by 20.24 percent. This is a 7.45 percent increase over earnings of $0.94 per share
Needham Maintains Buy on N-able, Raises Price Target to $13
Needham analyst Mike Cikos maintains N-able (NYSE:NABL) with a Buy and raises the price target from $12 to $13.